Raman Pharma is a UK based MHRA and VMD Licensed Wholesaler supplying to the Human and Veterinary Market. We are a family run company ambitiously changing the face of the Pharmaceutical and Veterinary Market alike in order to serve the needs of our customers and their patients.
Our Philosophy and business are structured around the requirements of our customers and we are committed to giving them our upmost attention and care. We believe in delivering quality and value to our customers wherever they may be.
The Herbal Horse and Pet is a South African manufacturer of a very innovative range of supplements for horses, dogs and cats. Their philosophy of using a large number of different ingredients in small amounts mimics nature in that the healing effect of the ingredients is maximised while undesirable side-effects are minimised. These unique formulations, in conjunction with 21st century scientific research and techniques are what they call “cutting edge nature”.
They are manufactured in a GMP Compliant Factory and has a large following from riders and pet owners across the world. Please follow the link to the website – www.theherbalhorse.co.uk to see all the amazing blogs and the ability to purchase these products online. The Equine and Pet Range were introduced to the UK Market in September 2014 by Raman Pharma to give the UK a taste of the future in equine and companion animal nutritional supplements.
"Fantastic service, Really helpful & always able to source products that we need at very competitive prices. Would thoroughly recommend to any Veterinary Practice"
"Raman Pharma have been invaluable in sourcing drugs that are out of stock elsewhere. Delivery is rapid, costs are good and the customer service provided by Dhruv is excellent. I would definitely recommend this company and its services to others."
This PSNC Briefing provides community pharmacy contractors with examples of suggested evidence, in a checklist format, that they can use to confirm they have the necessary evidence ready to make their Pharmacy Quality Scheme (PQS) declaration between 14th July 2020 and 23:59 on 29th January 2021. It is important that contractors have this evidence to...
A new Pharmacy Quality Scheme (PQS) for the first part of 2020/21 has been announced today (13th July 2020). The focus of the scheme is ensuring community pharmacy contractors and their teams have put in place all reasonable measures to respond to the COVID-19 pandemic, protecting both themselves and the people using their services. This...
Following the publication of Professor David Wright’s review into community pharmacy contractor support and representation, thank you to all contractors who took part in Professor Wright’s webinar on this topic. If you missed it, you can watch an on-demand version on his website. You can also find the full report on that website, and PSNC’s...
Community pharmacy contractors are being asked to declare their progress on performing COVID-19 risk assessments for their staff. At the end of June, NHS England and NHS Improvement (NHSE&I) requested that individual risk assessments for at least staff in at-risk group (including Black, Asian and Minority Ethic (BAME) staff) should be completed within a month...
Negotiations on high-level community pharmacy costs and funding throughout the COVID-19 pandemic have now formally begun, PSNC has today (July 8th) confirmed. The negotiations between PSNC, the Department of Health and Social Care (DHSC) and NHS England and NHS Improvement (NHSE&I) follow several months of representations by PSNC, including the submission of a business case...
Pharmacies who took part in the Pharmacy Advice Audit are requested to submit their data to PSNC urgently. Last week community pharmacy teams were encouraged to undertake PSNC’s audit to capture information about the advice they give to their patients and local communities. The data gathered will help demonstrate the added value pharmacies offer and...
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sodium Cromoglicate (Intal) CFC-free 5mg inhaler (Sanofi) Sodium Cromoglicate (Intal) CFC-free 5mg inhalers are out of stock until mid-November 2020. Unlicensed supplies have been sourced in sufficient quantities to cover the out of stock period. There is currently no listing on...
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Ferrous Fumarate 322mg/Folic Acid 350mcg (Pregaday) tablets (Recipharm) Pregaday tablets will be out of stock until October 2020. UKMI have provided clinical advice on switching to alternative iron and folic acid containing products. The DHSC Medicine Supply Team provide a monthly...
Community pharmacy teams have until 10th July 2020 to capture information about the advice they give to their patients and local communities, and submit that data to PSNC via PharmOutcomes. Last week pharmacies were encouraged to undertake the PSNC Pharmacy Advice Audit to capture information about the advice they give to their patients and local communities. The...
The number of flu vaccinations administered by community pharmacists under the NHS Advanced service grew by 20% in 2019/20 compared to the previous year, with 1,718,147 administrations being claimed to the end of March (NHSBSA data). This excellent growth rate continues to demonstrate that the convenience and accessibility of the pharmacy service is highly valued...
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Summary list of field safety notices (FSNs) from medical device manufacturers from 06 July to 10 July 2020
These temporary good manufacturing practice (GMP) flexibilities will be allowed to address the current exceptional circumstances
List of manufacturers and their medical devices which have been granted an exemption by the MHRA
The different types of tests and testing kits for COVID-19, and the specifications for manufacturers.
Manufactured by Synthes GmbH – cracking of the USS II Polyaxial 3D Head rings may result in loosening of the fixation system prior to completion of bone healing.
Today’s publication of the Independent Medicines and Medical Devices Safety Review is of profound importance for the MHRA, since the safety of the public is our first priority.
Guidance on how to get an e-cigarette on the market in the UK, including the notification scheme and reporting problems with e-cigarettes.
Summary list of field safety notices (FSNs) from medical device manufacturers from 29 June to 03 July 2020
Manufactured by Abbott – cases of valvular insufficiency and early revision.
Warning that thermal cameras and other such “temperature screening” products, some of which make direct claims to screen for COVID-19, are not a reliable way to detect if people have the virus.
List of sites granted a manufacturer or wholesale dealer licence
List of companies in the UK who have their licence to manufacture or wholesale medicines terminated and cancelled.
Medicines that were granted a positive opinion under the early access to medicines scheme (EAMS) which has now expired.
Expected time taken to process and grant a marketing authorisation or a variation to a marketing authorisation.
Information for clinicians and patients.
How to join the phase I accreditation scheme.
Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.
BCM Specials Limited is recalling a specific batch of Mepacrine Hydroxychloride 100 mg tablets due to a number of foreign body particulates found in the containers of the API used to make it.
Information on Medicines and Healthcare products Regulatory Agency spending over £25,000.
Licences, certificates and special rules for bringing goods into the UK from 1 January 2021.
As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.
News and guidance on veterinary medicines issues affected by coronavirus (COVID-19).
Relaxation of enforcement during the coronavirus (COVID-19) outbreak.
Relaxation of enforcement during the coronavirus (COVID-19) outbreak
Enforcement of Veterinary Medicines Regulations relaxed in light of enhanced precautions required by the response to coronavirus (COVID-19).
Temporary change to the standard VMD guidance on Manufacturers of extemporaneous preparations for use under the cascade (ManSA).
Relaxation of enforcement during the coronavirus (COVID-19) outbreak.
How to legally run a business that deals with the wholesale of animal medicines (veterinary medicinal products) and the WDA Register.
The Special Imports System will be unavailable on the weekend of 20 and 21 June 2020 due to essential IT maintenance .
Details of seizure notice served at Border Force, Inverness Airport following a routine search. Published in June 2020.
Privacy notices regarding personal data processed by the VMD for the administration of Pharmacovigilance, Inspections, applications for Import Certificates (SIC, WDIC and RIC) also for employees and contractors.
This strategy sets out Defra’s equality, diversity and inclusion priorities from 2020 to 2024.
Guidance on applying for an authorisation to manufacture veterinary medicines.
You must get permission to export certain drugs and medicines.
Request to not send post to the VMD office.
Residues of veterinary medicines in food 2020 surveillance results.
Residues of veterinary medicines in food 2019 surveillance results.
The VMD virtual office will be closed on Monday 25 and Tuesday 26 May.
Marketing Authorisation Holders (MAHs) have informed the VMD of supply problems with the following lactating cow intramammary antibiotics.
The drug did not extend progression-free survival in patients with newly diagnosed advanced stage ovarian cancer
The mRNA-based vaccines are currently being evaluated in Phase I/II clinical trials in Germany and the US
Fadraciclib is a dual inhibitor of CDK2 and CDK9
COVID-19 deaths could reach 119,000 between September 2020 and June 2021 if no action is taken
Clinigen has bagged a US orphan drug designation (ODD) for its investigational Amyotrophic Lateral Sclerosis (ALS) treatment aldesleukin.
The two agencies have agreed to share research and knowledge
Phase I/II study results demonstrate proof-of-concept and proof-of-biology of tofersen
More than 152,000 new cases of NMSC are diagnosed every year - more than breast, prostate and lung cancers combined
The drug hit primary and secondary goals of the Phase III FIDELIO-DKD renal outcomes study
Joint commitment led by the Royal Society of Chemistry, which has created a framework to reduce bias and discrimination that it is hoped 'will help reshape journals all over the world'
Brilinta/aspirin combo could be the first US-approved dual antiplatelet therapy to cut risk of second stroke
UK’s leading stroke charity warns research faces long-term threat due to coronavirus pandemic
Standard of care in untreated systemic anaplastic large cell lymphoma (sALCL) has not changed in several decades
The fines are in addition to £8 million secured for the NHS last year as part of the case
Regulators rejected accelerated approval as Roche's combination for the same patient population made it over the line first
Unit 2 Fleet Business Park, Sandy Lane, Church Crookham, Fleet, Hampshire, GU52 8BF
Pharmaceutical and Veterinary Licensed Distributor. WDA (H) 43703 & WDA (V) 43703.
- +44 (0)1252 260 460.
- +44 (0)1276 469 290
Monday to Friday - 09:30 – 18:30
Saturday & Sunday - Closed, Online Ordering Available
